- Fund Type: Open-End Fund
- Objective: Govt/Agency-Short Term
- Asset Class: Debt
- Geographic Focus: Mexico
Afirme - AfirVis SA de CV SIID
+ Add to WatchlistAFIRVIB2:MM
157.95 MXN 0.000.00%As of 09:29:30 ET on 05/22/2013.
Snapshot for Afirme - AfirVis SA de CV SIID (AFIRVIB2)
| Year To Date: | +0.53% | 3-Month: | +0.29% | 3-Year: | +1.59% | 52-Week Range: | 155.46 - 157.95 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +0.10% | 1-Year: | +1.60% | 5-Year: | +2.01% | Beta vs FINDIVID: | 0.33 |
Fund Profile & Information for AFIRVIB2
AfirVis SA de CV SIID is an open-end fund incorporated in Mexico. The Fund's objective is to achieve high returns through investments in a portfolio of short-term government fixed-income securities.
| Inception Date: | 02-05-2008 | Telephone: | 52-81-8318-3900 |
|---|---|---|---|
| Managers: | ALFONSO VILLARREAL LOOR | ||
| Web Site: | www.afirme.com.mx | ||
Fundamentals for AFIRVIB2
| NAV | (on 2013-05-22) 157.95 |
|---|---|
| Assets (M) | (on 2013-03-27) 169.15 |
| Fund Leveraged | N |
| Minimum Investment | 100,000.00 |
| Minimum Subsequent Investment | - |
Dividends for AFIRVIB2
No dividends reported
Fees & Expenses for AFIRVIB2
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.47 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for AFIRVIB2
Filing Date: 03/27/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| MBOND Float 03/20/14 | 300,000 | 30,002,300 | 24.761% |
| MBPA Float 10/02/14 | 249,330 | 24,895,957 | 20.546% |
| IFCTCB Float 12/15/14 | 209,972 | 21,181,642 | 17.481% |
| CFELEC Float 08/09/13 | 346,000 | 19,585,704 | 16.164% |
| CFELEC Float 04/12/13 | 150,000 | 15,028,614 | 12.403% |
| FNCO Float 04/15/13 | 5,500 | 5,513,247 | 4.550% |
| CFELEC Float 12/17/14 | 50,000 | 4,962,211 | 4.095% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page